190 related articles for article (PubMed ID: 23136314)
1. Patient perspective on watchful waiting/active surveillance for localized prostate cancer.
Xu J; Neale AV; Dailey RK; Eggly S; Schwartz KL
J Am Board Fam Med; 2012; 25(6):763-70. PubMed ID: 23136314
[TBL] [Abstract][Full Text] [Related]
2. Racial Differences in Treatment Decision-Making for Men with Clinically Localized Prostate Cancer: a Population-Based Study.
Xu J; Janisse J; Ruterbusch J; Ager J; Schwartz KL
J Racial Ethn Health Disparities; 2016 Mar; 3(1):35-45. PubMed ID: 26896103
[TBL] [Abstract][Full Text] [Related]
3. Men's perspectives on selecting their prostate cancer treatment.
Xu J; Dailey RK; Eggly S; Neale AV; Schwartz KL
J Natl Med Assoc; 2011 Jun; 103(6):468-78. PubMed ID: 21830629
[TBL] [Abstract][Full Text] [Related]
4. Active Surveillance Versus Watchful Waiting for Localized Prostate Cancer: A Model to Inform Decisions.
Loeb S; Zhou Q; Siebert U; Rochau U; Jahn B; Mühlberger N; Carter HB; Lepor H; Braithwaite RS
Eur Urol; 2017 Dec; 72(6):899-907. PubMed ID: 28844371
[TBL] [Abstract][Full Text] [Related]
5. Patient Knowledge and Qualities of Treatment Decisions for Localized Prostate Cancer.
Daum LM; Reamer EN; Ruterbusch JJ; Liu J; Holmes-Rovner M; Xu J
J Am Board Fam Med; 2017; 30(3):288-297. PubMed ID: 28484061
[TBL] [Abstract][Full Text] [Related]
6. Active surveillance for low-risk localized prostate cancer: what do men and their partners think?
Mallapareddi A; Ruterbusch J; Reamer E; Eggly S; Xu J
Fam Pract; 2017 Feb; 34(1):90-97. PubMed ID: 28034917
[TBL] [Abstract][Full Text] [Related]
7. The psychological impact of being on a monitoring pathway for localised prostate cancer: A UK-wide mixed methods study.
Matheson L; Wilding S; Wagland R; Nayoan J; Rivas C; Downing A; Wright P; Brett J; Kearney T; Cross W; Glaser A; Gavin A; Watson E
Psychooncology; 2019 Jul; 28(7):1567-1575. PubMed ID: 31132801
[TBL] [Abstract][Full Text] [Related]
8. 'It's not like you just had a heart attack': decision-making about active surveillance by men with localized prostate cancer.
Volk RJ; McFall SL; Cantor SB; Byrd TL; Le YC; Kuban DA; Mullen PD
Psychooncology; 2014 Apr; 23(4):467-72. PubMed ID: 24243777
[TBL] [Abstract][Full Text] [Related]
9. Quantifying the Transition from Active Surveillance to Watchful Waiting Among Men with Very Low-risk Prostate Cancer.
Van Hemelrijck M; Garmo H; Lindhagen L; Bratt O; Stattin P; Adolfsson J
Eur Urol; 2017 Oct; 72(4):534-541. PubMed ID: 27816297
[TBL] [Abstract][Full Text] [Related]
10. Racial Disparities in Active Surveillance for Prostate Cancer.
Krishna S; Fan Y; Jarosek S; Adejoro O; Chamie K; Konety B
J Urol; 2017 Feb; 197(2):342-349. PubMed ID: 27596691
[TBL] [Abstract][Full Text] [Related]
11. Perception of cancer and inconsistency in medical information are associated with decisional conflict: a pilot study of men with prostate cancer who undergo active surveillance.
Goh AC; Kowalkowski MA; Bailey DE; Kazer MW; Knight SJ; Latini DM
BJU Int; 2012 Jul; 110(2 Pt 2):E50-6. PubMed ID: 22145791
[TBL] [Abstract][Full Text] [Related]
12. Observation versus initial treatment for men with localized, low-risk prostate cancer: a cost-effectiveness analysis.
Hayes JH; Ollendorf DA; Pearson SD; Barry MJ; Kantoff PW; Lee PA; McMahon PM
Ann Intern Med; 2013 Jun; 158(12):853-60. PubMed ID: 23778902
[TBL] [Abstract][Full Text] [Related]
13. The New Surveillance, Epidemiology, and End Results Prostate with Watchful Waiting Database: Opportunities and Limitations.
Jeong CW; Washington SL; Herlemann A; Gomez SL; Carroll PR; Cooperberg MR
Eur Urol; 2020 Sep; 78(3):335-344. PubMed ID: 31980309
[TBL] [Abstract][Full Text] [Related]
14. Quality of Life after Radical Prostatectomy or Watchful Waiting With or Without Androgen Deprivation Therapy: The SPCG-4 Randomized Trial.
Johansson E; Steineck G; Holmberg L; Johansson JE; Nyberg T; Bill-Axelson A;
Eur Urol Oncol; 2018 Jun; 1(2):134-142. PubMed ID: 31100237
[TBL] [Abstract][Full Text] [Related]
15. Radical prostatectomy versus deferred treatment for localised prostate cancer.
Vernooij RW; Lancee M; Cleves A; Dahm P; Bangma CH; Aben KK
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD006590. PubMed ID: 32495338
[TBL] [Abstract][Full Text] [Related]
16. Decision-making processes among men with low-risk prostate cancer: A survey study.
Hoffman RM; Van Den Eeden SK; Davis KM; Lobo T; Luta G; Shan J; Aaronson D; Penson DF; Leimpeter AD; Taylor KL
Psychooncology; 2018 Jan; 27(1):325-332. PubMed ID: 28612468
[TBL] [Abstract][Full Text] [Related]
17. Utilization of Active Surveillance and Watchful Waiting for localized prostate cancer in the daily practice.
Herden J; Weissbach L
World J Urol; 2018 Mar; 36(3):383-391. PubMed ID: 29330583
[TBL] [Abstract][Full Text] [Related]
18. Socioeconomic determinants are associated with the utilization and outcomes of active surveillance or watchful waiting in favorable-risk prostate cancer.
Huang D; Ruan X; Huang J; Zhang N; Jiang G; Gao Y; Xu D; Na R
Cancer Med; 2023 Apr; 12(8):9868-9878. PubMed ID: 36727535
[TBL] [Abstract][Full Text] [Related]
19. Is 'watchful waiting' a real choice for men with prostate cancer? A qualitative study.
Chapple A; Ziebland S; Herxheimer A; McPherson A; Shepperd S; Miller R
BJU Int; 2002 Aug; 90(3):257-64. PubMed ID: 12133062
[TBL] [Abstract][Full Text] [Related]
20. Determinants of active surveillance uptake in a diverse population-based cohort of men with low-risk prostate cancer: The Treatment Options in Prostate Cancer Study (TOPCS).
Xu J; Bock CH; Janisse J; Woo J; Cher ML; Ginsburg K; Yacoub R; Goodman M
Cancer; 2024 May; 130(10):1797-1806. PubMed ID: 38247317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
